Overview
- 5 public-safe observations are available for this inspection.
- 5 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
5 May 2025
21 CFR 111.123(b)(2)
Quality control - batch, product specifications
Cited by Meredith P Soehl, Jung K Kim
5 May 2025
21 CFR 111.205(b)(1)
Master manufacturing record - specifications, quality; packaging, labeling
Cited by Meredith P Soehl, Jung K Kim
5 May 2025
21 CFR 111.315(d)
Standard reference materials; criteria for selecting
Cited by Meredith P Soehl, Jung K Kim
5 May 2025
21 CFR 111.70(e)
Specifications - finished dietary supplement
Cited by Meredith P Soehl, Jung K Kim
Inspected site
BABio Answer Holdings, Inc.Hauppauge, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 111.123(b)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.205(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.315(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.70(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.70(e) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere